ANGLE plc (LON:AGL – Get Free Report)’s stock price was up 2.8% during trading on Thursday . The stock traded as high as GBX 8.68 ($0.11) and last traded at GBX 8.22 ($0.11). Approximately 469,791 shares were traded during trading, a decline of 78% from the average daily volume of 2,164,704 shares. The stock had previously closed at GBX 8 ($0.10).
Wall Street Analysts Forecast Growth
Separately, Berenberg Bank reaffirmed a “buy” rating and set a GBX 70 ($0.92) price objective on shares of ANGLE in a research note on Thursday, September 26th.
Check Out Our Latest Stock Report on ANGLE
ANGLE Stock Performance
ANGLE Company Profile
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.
Recommended Stories
- Five stocks we like better than ANGLE
- Pros And Cons Of Monthly Dividend Stocks
- 3 Micro-Caps Set for Major Moves: Balancing Risk and Opportunity
- What Makes a Stock a Good Dividend Stock?
- Autodesk Named a “Top Pick” by Morgan Stanley—Is It Time to Buy?
- 10 Best Airline Stocks to Buy
- 4 Quirky ETFs With Big Potential for Impressive Gains
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.